Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleBrain

Decreased Diffusion in Central Pontine Myelinolysis

Steven C. Cramer, Keith C. Stegbauer, Alex Schneider, John Mukai and Kenneth R. Maravilla
American Journal of Neuroradiology September 2001, 22 (8) 1476-1479;
Steven C. Cramer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith C. Stegbauer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Schneider
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Mukai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth R. Maravilla
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

Summary: Two patients with central pontine myelinolysis (CPM) were studied with diffusion-weighted MR imaging 1 week after onset of tetraplegia. In both patients, affected white matter showed hyperintensity on diffusion-weighted images associated with a decrease in apparent diffusion coefficient (ADC) values. In one patient studied serially, ADC values normalized by 3 weeks after tetraplegia. Early in the clinical course, diagnosis of CPM can sometimes be difficult. Hyperintensity on diffusion-weighted images may therefore have diagnostic utility. Decreased lesional ADC values support the notion that CPM is a consequence of relative intracellular hypotonicity.

Central pontine myelinolysis (CPM) is an uncommon consequence of certain metabolic derangements. These include rapid correction of hyponatremia, as well as hyperosmolar conditions, such as hyperglycemia. The microscopic appearance of CPM is loss of myelin with sparing of axons, without evidence of inflammation (1, 2). The abnormalities associated with CPM are readily identified on T2-weighted MR imaging scans (3). Little information is available regarding the characteristics of CPM revealed by diffusion-weighted (DW) imaging. Such information may be of diagnostic value and might also provide insight into the pathogenesis of this disorder. The current study considers these issues in reporting DW imaging results in two patients with CPM.

Case Reports

Case 1

A 27-year-old man presented to a community hospital with 2 days' delirium. He consumed alcohol daily for 1 year, including more than a case of beer per day for 3 months. Two days prior to admission, he developed nausea and vomiting and abruptly ceased alcohol intake. The admitting examination was remarkable for lethargy, confusion, and agitation. Serum sodium was 105 mEq/L. Cerebrospinal fluid and noncontrast head CT findings were unremarkable. Administration of intravenous saline increased serum sodium to 126 mEq/L over an 18-hour period. Over the next 3 days, he developed spastic tetraplegia and respiratory failure.

MR images obtained 6 days after developing tetraplegia showed mild T2 hyperintensity restricted to the pons, and DW images showed hyperintensity in the same region (Fig 1A–D). Apparent diffusion coefficient (ADC) maps were derived on a voxel-by-voxel basis using the following formula: [ln (T2 signal) − ln (DWI)]/1000. ADC was decreased in abnormal pontine regions (0.39 ± 0.14 × 10−3 mm2/s; mean ± SD) and was normal in unaffected white matter (0.90 ± 0.15 × 10−3 mm2/s). MR angiography of cervical and intracranial arteries was normal. The patient was transferred to University of Washington Medical Center and on day 21 after tetraplegia, repeat MR imaging (Fig 1E–H) showed areas of hyperintensity on T2-weighted images in the pons, as well as bilateral internal capsules. DW images also showed hyperintensity, but this was due to shine-through of T2 brightness because ADC was now normal in all of these areas. By 10 weeks, the patient's neurologic examination was entirely normal, apart from very mild abnormalities of tone and balance, plus a new intention tremor.

fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
fig 1.

Case 1. MR images obtained using a 1.5-T magnet. Images for study 1 (A–D) were taken in an oblique axial plane 6 days after development of tetraplegia. Images for study 2 (E–H) were taken in an axial plane 21 days after development of tetraplegia.

A, DW image shows increased signal intensity in pons due to restricted water diffusion.

B, DW image is normal in the internal capsules bilaterally.

C and D, In the pons, there is little hyperintensity on the T2-weighted images and low ADC values, with mean ADC in basis pontis being 0.39 ± 0.14 × 10−3 mm2/s (mean ± SD) compared with 0.90 ± 0.15 × 10−3 mm2/s in unaffected white matter.

E, DW image shows increased signal intensity still present in the pons.

F, The DW image shows increased signal intensity present in the internal capsules bilaterally.

G and H, The DW abnormality is accounted for by shine-through from the hyperintense T2-weighted images. Mean ADC in basis pontis (1.09 ± 0.10 × 10−3 mm2/s) is normal compared with that of unaffected white matter (1.05 ± 0.09 × 10−3 mm2/s).

Case 2

A 60-year-old man with end-stage liver disease due to hepatitis B was admitted for hepatic encephalopathy. Five days prior to admission, the patient was ambulatory and had a serum sodium of 115 mEq/L. An initial neurologic examination showed confusion but normal motor function. From days 8–13 of admission, serum sodium ranged from 150 to 155 mEq/L. On approximately day 14, he developed a spastic tetraplegia. Head CT and Doppler studies of internal carotid and vertebral arteries were unremarkable.

MR images obtained 7 days after developing tetraplegia (Fig 2) showed hyperintensity within the pons and the thalami bilaterally, consistent with CPM with extrapontine involvement. DW images also showed increased signal in these areas. ADC was decreased in the pons (0.62 ± 0.11 × 10−3 mm2/s) and in the thalamus (0.43 ± 0.09 × 10−3 mm2/s) compared with that of unaffected white matter (0.82 ± 0.12 × 10−3 mm2/s). The patient died 21 days after tetraplegia.

fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
fig 2.

Case 2. Images obtained in the axial plane 7 days after development of tetraplegia. DW (A and B) and T2-weighted (C and D) images show increased signal intensity within the pons and the thalami bilaterally, consistent with CPM with extrapontine involvement. ADC is decreased in affected pontine (0.62 ± 0.11 × 10−3 mm2/s) and thalamic (0.43 ± 0.09 × 10−3 mm2/s) regions compared with that of unaffected white matter (0.82 ± 0.12 × 10−3 mm2/s). The patient died before repeat images could be obtained

Discussion

The clinical presentation of these patients is consistent with CPM (4) with extrapontine myelinolysis arising as a result of an increase in serum sodium. CPM was ultimately distinguished from basilar artery disease by the clinical history, the presence of spastic tetraplegia without tegmental signs, and the absence of cerebrovascular disease or significant ischemic insult. Furthermore, clinical recovery in patient 1 was excellent.

Early in the course, the clinical diagnosis of CPM can be challenging (4). Hyperintensity seen within the CPM lesions on DW images of both patients (Figs 1 and 2) after 1 week is of diagnostic utility. The DW findings do not distinguish CPM from ischemia (5), where ADC values are also decreased early in the course. However, ADC values within affected brain areas may be increased in other conditions that may clinically be confused with CPM. Conditions in which increased ADC values may be seen include certain brain tumors, acute disseminated encephalomyelitis, and multiple sclerosis (MS) (5–7). DW imaging is useful to distinguish these conditions from CPM because affected brain areas in patients with CPM show decreased ADC values (Figs 1 and 2). DW imaging is also useful to distinguish CPM from patients whose neurologic abnormalities arise from a psychiatric condition, in whom ADC values would presumably be normal. Both patients in the current report showed hyperintensity on T2-weighted images of the pons, but previous reports of patients with CPM have described a delay in appearance of T2-weighted MR imaging abnormalities (4, 8). DW images become sensitive at very early time points after ischemic brain injury (5). If the same is true for CPM, then diagnosis in patients with suspected acute CPM but normal T2-weighted MR images may be improved by the addition of DW imaging.

Experimental studies in animals have suggested a number of hypotheses regarding the pathogenesis of myelinolysis in CPM, including excessive brain dehydration (9), intramyelinic and neuronal edema (10), and cerebral vascular endothelial dysfunction (11). Clinical studies have suggested that some cases may be due to an overshoot of brain sodium during treatment of hyponatremia (12) or compression of myelin by swollen cellular elements (13). McKee et al (2) suggested that CPM arises when the extracellular fluid is made to be relatively hypertonic compared with intracellular fluid, regardless of the absolute osmolality or the identity of the dysequilibrated molecule. The mechanism of white matter dysfunction in CPM might also involve axonal swelling. Astrocytic swelling is also quite prominent in brain edema (14), and the contribution of glia to ADC values has not been precisely determined.

The current observations support the hypothesis that in humans, CPM is a consequence of a relatively hypotonic intracellular compartment. Intra-lesional ADC values were decreased in both patients 6–7 days after developing tetraplegia. There is experimental evidence that decreased ADC is associated with restricted water diffusion and increased intracellular water. For example, Anderson et al (15) found a decrease in ADC during osmotically driven axonal swelling, while cell shrinkage was associated with an increase in ADC. In MS, a condition with pathologic findings that partially overlap with CPM, ADC values within acutely demyelinated regions increase rather than decrease. Increased ADC values in MS may reflect expanded extracellular volume (7), whereas decreased ADC values in the current CPM patients likely reflect expansion of intracellular volume relative to extracellular volumes. The rise in ADC in patient 1 from day 6 to day 21 may reflect the rate with which certain intracellular osmolytes levels return to normal (12).

The differences in MR appearances between the pontine and capsular lesions in the first study of patient 1 (Fig 1A–D) might suggest that lesions at the two sites were of different ages, as has been described in patients with CPM (16); note that no osmolar insults occurred between the two MR studies. The cellular composition is quite different between pons and internal capsule. As a result, post-CPM histopathologic reactions (summarized by McKee et al [2]) may be dissimilar between these two areas and therefore may have contributed to these differences in MR appearance.

CPM is a disease that may arise in several settings and has a highly variable clinical outcome (4, 17). Early in the course, DW imaging may have diagnostic value. Results suggest relative intracellular hypotonicity, which has been hypothesized as a key event in the pathogenesis of CPM. The appearance of CPM lesions on T2-weighted MR images is often delayed (4, 8). Further studies are needed to determine the diagnostic utility of DW imaging immediately after onset of symptoms suggestive of CPM.

Footnotes

  • 1 Address reprint requests to Steven C. Cramer, MD, University of Washington, Department of Neurology, 1959 N.E. Pacific Street, Box 356465, Seattle, WA 98195.

References

  1. ↵
    Adams RA, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholics and malnourished patients. Arch Neurol Psychiat 1959;81:154-172
  2. ↵
    McKee AC, Winkelman MD, Banker BQ. Central pontine myelinolysis in severely burned patients: relationship to serum hyperosmolality [published erratum appears in Neurology 1988;38:1662]. Neurology 1988;38:1211-1217
    Abstract/FREE Full Text
  3. ↵
    Yuh WT, Simonson TM, D'Alessandro MP, Smith KS, Hunsicker LG. Temporal changes of MR findings in central pontine myelinolysis. AJNR Am J Neuroradiol 1995;16:975-977
    Abstract
  4. ↵
    Karp BI, Laureno R. Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia. Medicine (Baltimore) 1993;72:359-373
    PubMed
  5. ↵
    Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000;217:331-345
    CrossRefPubMed
  6. Noguchi K, Watanabe N, Nagayoshi T, et al. Role of diffusion-weighted echo-planar MRI in distinguishing between brain abscess and tumour: a preliminary report. Neuroradiology 1999;41:171-174
    CrossRefPubMed
  7. ↵
    Horsfield MA, Larsson HB, Jones DK, Gass A. Diffusion magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;64:S80-S84
  8. Kumar SR, Mone AP, Gray LC, Troost BT. Central pontine myelinolysis: delayed changes on neuroimaging. J Neuroimaging 2000;10:169-172
    CrossRefPubMed
  9. ↵
    Soupart A, Decaux G. Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications. Clin Nephrol 1996;46:149-169
    PubMed
  10. ↵
    Rojiani AM, Prineas JW, Cho ES. Electrolyte-induced demyelination in rats. 1. Role of the blood-brain barrier and edema. Acta Neuropathol (Berl) 1994;88:287-292
    PubMed
  11. ↵
    Norenberg MD. A hypothesis of osmotic endothelial injury: a pathogenetic mechanism in central pontine myelinolysis. Arch Neurol 1983;40:66-69
    CrossRefPubMed
  12. ↵
    Verbalis JG, Gullans SR. Rapid correction of hyponatremia produces differential effects on brain osmolyte and electrolyte reaccumulation in rats. Brain Res 1993;606:19-27
    CrossRefPubMed
  13. ↵
    Tomlinson BE, Pierides AM, Bradley WG. Central pontine myelinolysis: two cases with associated electrolyte disturbance. Q J Med 1976;45:373-386
    Abstract/FREE Full Text
  14. ↵
    Kimelberg HK. Brain edema. In: Kettenmann H, Ransom B, eds. Neuroglia. New York: Oxford University Press 1995;919-935
  15. ↵
    Anderson AW, Zhong J, Petroff OA, et al. Effects of osmotically driven cell volume changes on diffusion-weighted imaging of the rat optic nerve. Magn Reson Med 1996;35:162-167
    PubMed
  16. ↵
    Gocht A, Colmant HJ. Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol 1987;6:262-270
    PubMed
  17. Menger H, Jorg J. Outcome of central pontine and extrapontine myelinolysis (n = 44). J Neurol 1999;246:700-705
    CrossRefPubMed
  • Received December 18, 2000.
  • Accepted after revision April 20, 2001.
  • Copyright © American Society of Neuroradiology
View Abstract
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 22 (8)
American Journal of Neuroradiology
Vol. 22, Issue 8
1 Sep 2001
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Decreased Diffusion in Central Pontine Myelinolysis
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
Steven C. Cramer, Keith C. Stegbauer, Alex Schneider, John Mukai, Kenneth R. Maravilla
Decreased Diffusion in Central Pontine Myelinolysis
American Journal of Neuroradiology Sep 2001, 22 (8) 1476-1479;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Decreased Diffusion in Central Pontine Myelinolysis
Steven C. Cramer, Keith C. Stegbauer, Alex Schneider, John Mukai, Kenneth R. Maravilla
American Journal of Neuroradiology Sep 2001, 22 (8) 1476-1479;
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Case Reports
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Central pontine myelinolysis in a case of cerebral malaria
  • Central pontine myelinolysis associated with hypokalaemia in anorexia nervosa * Authors' reply
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Usefulness of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson Disease
  • White Matter Alterations in the Brains of Patients with Active, Remitted, and Cured Cushing Syndrome: A DTI Study
  • Qualitative and Quantitative Analysis of MR Imaging Findings in Patients with Middle Cerebral Artery Stroke Implanted with Mesenchymal Stem Cells
Show more Brain

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire